help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 70, No. 4 930-938
doi:10.1210/jcem-70-4-930
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PARISIEN, M.
Right arrow Articles by DEMPSTER, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PARISIEN, M.
Right arrow Articles by DEMPSTER, D. W.

The Histomorphometry of Bone in Primary Hyperparathyroidism: Preservation of Cancellous Bone Structure*

MAY PARISIEN, SHONNI J. SILVERBERG, ELIZABETH SHANE, LUZ DE LA CRUZ, ROBERT LINDSAY, JOHN P. BILEZIKIAN and DAVID W. DEMPSTER

Regional Bone Center, Helen Hayes Hospital (New York State Department of Health) (M.P., R.L., D. W.D.) West Haverstraw, New York 10993
the Departments of Medicine (S.J.S., E.S., L.D.L.C., R.L., J.P.B.), Pathology (M.P., D. W.D.), and Pharmacology (J.P.B.), Columbia University College of Physicians and Surgeons New York, New York 10032

Address all correspondence and requests for reprints to: May Parisien, M.D., Regional Bone Center, Helen Hayes Hospital, Route 9W, West Haverstraw, New York 10993.

To evaluate the effects of primary hyperparathyroidism (PHPT) on bone mass and structure, we have studied the iliac crest biopsies of 27 patients, 10 males (28–68 yr old) and 17 females (26–72 yr old) with mild PHPT after in vivo tetracycline labeling. All patients had mild hypercalcemia in the absence of any other cause and elevated levels of PTH without radiological evidence of bone disease. Static parameters of bone turnover (osteoid surface, osteoid volume, and eroded surface) were elevated in both men and women compared to normal values; the midmolecule RIA for PTH (PTHMM) was positivelycorrelated with osteoid surface (r = 0.44; P < 0.025) and eroded surface (r = 0.58; P < 0.005). Dynamic parameters of bone turnover (mineralizing surface, expressed as double plus half single labeled surface, and bone formation rate at tissue level) were elevated compared to normal values; PTHMM was positivelycorrelated with double plus half single labeled surfaces (r = 0.33; P < 0.05) and with bone formation rate at the tissue level (r = 0.37; P < 0.05). The mineral apposition rate was within the limits of normal values and positively correlated with PTHMM (r = 0.34; P < 0. 05). Histomorphometric parameters of bone structure [cancellous bone volume (BV/TV), trabecular thickness (Tb. Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), cortical thickness (Ct.Th), and total bone density (TBD)] were compared to those in 20 autopsy control subjects, 12 men (33–60 yr old) and 8 women (27–75 yr old). BV/TV and Tb.N were significantly higher in PHPT patients than controls (P < 0.02 and P < 0.001, respectively). Tb.Sp was significantly lower in PHPT patients than controls (P < 0.001), whereas Tb.Th was not significantly different between PHPT patients and controls. Ct.Th was significantly lower in PHPT patients than in controls (P < 0.001), whereas TBD was not significantly different between the two groups. BV/TV was negatively correlated with age in both controls and PHPT patients. Tb.N showed a negative correlation and Tb.Sp a positive correlation with age i n controls (r = –0.47; P < 0.05 and r = 0.52; P < 0.02, respectively), but they were not significantly dependent on age in PHPT patients. Tb.Th, while showing no significant age-related change in controls, was negatively correlated with age in PHPT patients (r = –0.42; P < 0.05). Ct.Th correlated negatively with age in controls (r = –0.46; P < 0.05), but showed no age dependency in PHPT patients. In conclusion, our data showed that compared to normal subjects, patients with PHPT have increased bone turnover, thinning of cortical bone, and increased cancellous bone volume. We propose that a different mechanism of age-related bone loss in PHPT allows the striking maintenance of well connected trabecular plates, and that increased levels of PTH, therefore, may have a protective effect on cancellous bone.

* A preliminary report of this work was presented at the Fifth International Workshop on Bone Histomorphometry, Niigata, Japan, September 1988. This work was supported in part by the NIH Grants DK-32333, AR-35647, AR-39191, and DK-01836.

Received June 13, 1989.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Bollerslev, T. Rosen, C. L. Mollerup, J. Nordenstrom, M. Baranowski, C. Franco, Y. Pernow, G. A. Isaksen, K. Godang, T. Ueland, et al.
Effect of Surgery on Cardiovascular Risk Factors in Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2255 - 2261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ohishi, R. Chiusaroli, M. Ominsky, F. Asuncion, C. Thomas, R. Khatri, P. Kostenuik, and E. Schipani
Osteoprotegerin Abrogated Cortical Porosity and Bone Marrow Fibrosis in a Mouse Model of Constitutive Activation of the PTH/PTHrP Receptor
Am. J. Pathol., June 1, 2009; 174(6): 2160 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Rubin, J. P. Bilezikian, D. J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, and S. J. Silverberg
The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3462 - 3470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Zoehrer, D. W. Dempster, J. P. Bilezikian, H. Zhou, S. J. Silverberg, E. Shane, P. Roschger, E. P. Paschalis, and K. Klaushofer
Bone Quality determined by Fourier Transform Infrared Imaging Analysis in Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3484 - 3489.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Chavassieux, E. Seeman, and P. D. Delmas
Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease
Endocr. Rev., April 1, 2007; 28(2): 151 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. L. Nickolas, D. J. McMahon, and E. Shane
Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3223 - 3232.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Kaji, M. Yamauchi, K. Chihara, and T. Sugimoto
The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism
Eur. J. Endocrinol., September 1, 2005; 153(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sakamoto, M. Chen, T. Nakamura, T. Xie, G. Karsenty, and L. S. Weinstein
Deficiency of the G-protein {alpha}-Subunit Gs{alpha} in Osteoblasts Leads to Differential Effects on Trabecular and Cortical Bone
J. Biol. Chem., June 3, 2005; 280(22): 21369 - 21375.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. Chen, H. Kaji, M.-F. Iu, R. Nomura, H. Sowa, M. Yamauchi, T. Tsukamoto, T. Sugimoto, and K. Chihara
Effects of an Excess and a Deficiency of Endogenous Parathyroid Hormone on Volumetric Bone Mineral Density and Bone Geometry Determined by Peripheral Quantitative Computed Tomography in Female Subjects
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4655 - 4658.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. K. W. Chan, S.-C. Tiu, K.-L. Choi, C.-H. Choi, A. P. S. Kong, and C.-C. Shek
Increased Bone Mineral Density in Patients with Chronic Hypoparathyroidism
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3155 - 3159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Rubin, K. H. Lee, D. J. McMahon, and S. J. Silverberg
Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1174 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. Parker, P. J. Blackwell, K. J. Fairbairn, and D. J. Hosking
Alendronate in the Treatment of Primary Hyperparathyroid-Related Osteoporosis: A 2-Year Study
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4482 - 4489.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Rubin and J. P. Bilezikian
The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
L. A. Fitzpatrick
Secondary Causes of Osteoporosis
Mayo Clin. Proc., May 1, 2002; 77(5): 453 - 468.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
P. Lips
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
Endocr. Rev., August 1, 2001; 22(4): 477 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Khastgir, J. Studd, N. Holland, J. Alaghband-Zadeh, S. Fox, and J. Chow
Anabolic Effect of Estrogen Replacement on Bone in Postmenopausal Women with Osteoporosis: Histomorphometric Evidence in a Longitudinal Study
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 289 - 295.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Nakaoka, T. Sugimoto, T. Kobayashi, T. Yamaguchi, A. Kobayashi, and K. Chihara
Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1901 - 1907.
[Abstract] [Full Text]


Home page
NEJMHome page
S. J. Silverberg, E. Shane, T. P. Jacobs, E. Siris, and J. P. Bilezikian
A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery
N. Engl. J. Med., October 21, 1999; 341(17): 1249 - 1255.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. W. Dempster, M. Parisien, S. J. Silverberg, X.-G. Liang, M. Schnitzer, V. Shen, E. Shane, D. B. Kimmel, R. Recker, R. Lindsay, et al.
On the Mechanism of Cancellous Bone Preservation in Postmenopausal Women with Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1562 - 1566.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Duan, V. De Luca, and E. Seeman
Parathyroid Hormone Deficiency and Excess: Similar Effects on Trabecular Bone But Differing Effects on Cortical Bone
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 718 - 722.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
L. J. Melton III, E. J. Atkinson, W. M. O'Fallon, and H. Heath III
Risk of Age-Related Fractures in Patients With Primary Hyperparathyroidism
Arch Intern Med, November 1, 1992; 152(11): 2269 - 2273.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society